Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic (PDF) 1 - 5 Users Enterprisewide Abnormal Uterine Bleeding: Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers Valid Results, April 2008   Description     Table of Contents        Enquire before Buying    Send to a Friend   The report identifies unmet needs in obstetrics and gynecology, both in the GEA market overall and for specific GEA manufacturers. It also assesses the fit of each product with its customers, and quantifies the percentage of a each products customers that may be at risk. Risk is evaluated by segmenting GEA customers who use a given product but whose needs will better met by a competitive product. Opportunities are supported by providing an understanding of surgeons perceptions of the importance of product considerations and the relative performance of featured products. Featured companies include: American Medical System, Boston Scientific, Cytyc/Hologic, Ethicon Women’s Health, and Microsulis. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order. The number of respondents to this survey is 40. We also have more studies available with increased survey respondents. Please use our Contact Us page for further details on pricing. Customers who bought this item also bought Opinions in Uterine Fibroid Management: Is there a need for pharmacological therapies? Abnormal Uterine Bleeding: Assessing the Strengths of Associations Between GEA Brands and their Manufacturers Abnormal Uterine Bleeding: Trends in Procedures for the Treatment of AUB Abnormal Uterine Bleeding: Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers Abnormal Uterine Bleeding: Considerations that Shape Product Preferences in Obstetric and Gynecology Abnormal Uterine Bleeding: Patient Characteristics and Treatment Modalities for AUB Abnormal Uterine Bleeding: Applying the 80/20 Rule to AUB Procedures Abnormal Uterine Bleeding: How Competing GEA Companies are Positioned in the Minds of Ob/Gyn Surgeons

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster